rhGH

DRUG5 trials

Sponsors

Hospices Civils de Lyon, Pennington Biomedical Research Center, Versartis Inc., Istituto Auxologico Italiano, Xiamen Amoytop Biotech Co., Ltd.

Conditions

GH DeficiencyGrowth DisordersIdiopathic Short StatureObesityShort Bowel SyndromeSmall for Gestational AgeTurner Syndrome

Phase 2

A Trial of YPEG-rhGH in Children With Short Stature

CompletedNCT05838885

Xiamen Amoytop Biotech Co., Ltd.Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome

Start: 2022-02-15End: 2023-12-19Updated: 2024-01-24

Phase 3

Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome

CompletedNCT00169637

Hospices Civils de LyonShort Bowel Syndrome

Start: 2006-06-01End: 2008-06-01Updated: 2026-05-06

Long-Acting Growth Hormone in Children Compared to Daily rhGH

CompletedNCT02339090

Versartis Inc.Growth Disorders

Start: 2015-08-26End: 2017-08-23Updated: 2022-12-30

Phase 4

Mechanism of Growth Hormone Effects on Adipose Tissue

CompletedNCT00453557

Pennington Biomedical Research CenterObesity

Start: 1999-04-30End: 2000-12-31Target: 30Updated: 2016-12-08

Unknown Phase

Vesiculogenesis in Children With GH Deficiency (VESCIGHTP)

Active, not recruitingNCT05759624

Istituto Auxologico ItalianoGH Deficiency

Start: 2022-06-24End: 2025-12-31Updated: 2024-10-02